Home » Newsletters » BioWorld Science

BioWorld Science

June 17, 1998

View Archived Issues

DuPont Merck's investigational ultrasound agent shows promise in phase III

Biomira and Chiron expand Theratope cancer vaccine agreement

Company Profile: Antigenics

Scientists uncover genetic mutations responsible for hereditary form of dementia

SDZ-WAG-994 useful for cardiovascular/metabolic complications in diabetes

Ciblex formed to exploit Exhibin technology

ISIS-2302 exhibits promising activity in phase II study for Crohn's disease

Agents for CMV and other herpesvirus infections described by P&U

PTPase active-site modulators from Ontogen: a novel approach to treating diabetes

Topical antiinflammatory corticosteroid approved for marketing in Japan

Insulin sensitizers developed at JT with potent hypoglycemic effects

ADIR describes new PDE IV-inhibitory flavones

Tetrahydrobenzo[a]fluorenes for postmenopausal symptoms and related disorders

CGRP receptor antagonists developed at SKB

Yissum discloses peptidomimetic protein farnesyltransferase inhibitors

New dihydrofolate reductase inhibitors with antitumor and antiparasitic activities

Santen evaluates LTA4 hydrolase inhibitor in models of dermatitis

Suntory initiates clinical testing of three new compounds

FDA extends review period for Thyrogen

Merck & Co. and Banyu collaborate on development of ET antagonist

Memric development on hold, SKB says

HT-PS system validation triggers Cadus equity investment in Axiom

Genome Therapeutics and Astra Research Center Boston extend alliance

Dopascan studied extensively for diagnosis of Parkinson's disease

Beta3-adrenoceptor agonist CL-316243 enhances insulin activity in humans

New dosing regimen of Avax melanoma vaccine results in improved outcome

Insulin sensitizer induces ovulation in women with PCOS

Potent in vivo antifungal activity of cordycepin in combination with ADA inhibitor

Xoma issued U.S. patent for new method of humanizing monoclonal antibodies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...